Aneira Health launches precision platform for women’s healthspan

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Led by figures from Oxford, Genomics England and the NHS, Aneira aims to tackle delays, data gaps and diagnostic bias in female healthcare.

When female-specific symptoms are filtered through diagnostic systems designed around the male body, it is perhaps unsurprising that outcomes fall short. With conditions such as endometriosis taking a decade to diagnose on average – and women still 50% more likely to experience adverse drug reactions due to underrepresentation in clinical research – the case for rethinking how healthcare is delivered to women has become increasingly urgent. The latest intervention in this space is Aneira Health: a new precision medicine platform founded by senior figures from Genomics England, Oxford University and the NHS, which launches with a stated ambition to rebuild care pathways from the biology up.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

Eleanor Garth

Editor

Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

With a keen interest in all things geroscience, Eleanor covers the biological mechanisms of aging, highlighting how interventions – from nutritional strategies to advanced therapeutics – can influence the aging process at a cellular level. She also investigates the broader implications of aging research, including the integration of longevity science into healthcare strategy and the expanding wellness economy. Her work (hopefully) provides insights into how these developments are shaping the emerging landscape of healthspan optimization and age-related innovation.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Oura spends $625m to put doctors behind its smart ring

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE